CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 77 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,314,483 | -42.9% | 445,550 | -35.4% | 0.33% | -39.6% |
| Q4 2022 | $18,078,000 | +33.3% | 690,000 | 0.0% | 0.55% | +37.5% |
| Q3 2022 | $13,565,000 | +12.4% | 690,000 | 0.0% | 0.40% | -4.1% |
| Q2 2022 | $12,068,000 | +6.9% | 690,000 | 0.0% | 0.42% | +18.1% |
| Q1 2022 | $11,288,000 | -14.2% | 690,000 | -25.9% | 0.35% | -28.3% |
| Q2 2021 | $13,155,000 | -32.3% | 931,650 | -25.5% | 0.49% | -42.9% |
| Q1 2021 | $19,425,000 | -2.0% | 1,250,001 | 0.0% | 0.86% | -19.1% |
| Q4 2020 | $19,825,000 | – | 1,250,001 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |